Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs
Is living donor liver transplantation really equivalent to deceased donor liver transplantation? *
Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival
Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods
Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome
The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation
Optimizing utilization of kidneys from deceased donors over 60 years: Five-year outcomes after implementation of a combined clinical and histological allocation algorithm
Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria
Four-year allograft survival in a highly sensitized combined liver–kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib
European survey on the management of tuberculosis in solid-organ transplant recipients and candidates
Calcineurin-inhibitor induced pain syndrome in a lung transplant patient
Corrigendum
Corrigendum
Corrigendum